EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.4.3.3 | sitting drop vapor diffusion method, using 10-15% (w/v) PEG 4000, 0.1 M sodium citrate, pH 8.0, 0.2 M ammonium dihydrogen phosphate, and 10% (v/v) glycerol | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.3 | 3-hydroxy-5-(2-phenylethyl)pyridin-2(1H)-one | - |
Homo sapiens | |
1.4.3.3 | 3-hydroxy-5-methylpyridin-2(1H)-one | - |
Homo sapiens | |
1.4.3.3 | 3-hydroxypyridin-2(1H)-one | - |
Homo sapiens | |
1.4.3.3 | 3-hydroxyquinolin-2(1H)-one | - |
Homo sapiens | |
1.4.3.3 | 4,6-difluoro-1-hydroxy-1H-benzo[d]imidazol-2(3H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-(1-phenylethyl)pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-(2-phenylethyl)pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-(3-phenylpropyl)pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-(phenoxymethyl)pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-[2-(3-methoxyphenyl)ethyl]pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-[2-(4-methoxyphenyl)ethyl]pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-[2-[2-(trifluoromethyl)phenyl]ethyl]pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-[2-[3-(trifluoromethyl)phenyl]ethyl]pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4-hydroxy-6-[2-[4-(trifluoromethyl)phenyl]ethyl]pyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 4H-furo[3,2-b]pyrrole-5-carboxylic acid | - |
Homo sapiens | |
1.4.3.3 | 4H-thieno[3,2-b]-pyrrole-5-carboxylic acid | - |
Homo sapiens | |
1.4.3.3 | 5-chloro-3-hydroxypyridin-2(1H)-one | - |
Homo sapiens | |
1.4.3.3 | 5-methylpyrazole-3-carboxylic acid | - |
Homo sapiens | |
1.4.3.3 | 6-(2-cyclohexylethyl)-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-(3,3-dimethylbutyl)-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-chlorobenzo[d]isoxazole-3-ol | - |
Homo sapiens | |
1.4.3.3 | 6-cyclohexyl-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[(E)-2-(4-chlorophenyl)vinyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[2-(2-fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[2-(3,5-difluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[2-(3,5-dimethoxyphenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[2-(3-fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[2-(4-chlorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[2-(4-fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | 6-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-4-hydroxypyridazin-3(2H)-one | - |
Homo sapiens | |
1.4.3.3 | benzoate | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.3 | D-amino acid + H2O + O2 | Homo sapiens | - |
2-oxocarboxylate + NH3 + H2O2 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.4.3.3 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.4.3.3 | D-alanine + H2O + O2 | - |
Homo sapiens | pyruvate + NH3 + H2O2 | - |
? | |
1.4.3.3 | D-amino acid + H2O + O2 | - |
Homo sapiens | 2-oxocarboxylate + NH3 + H2O2 | - |
? | |
1.4.3.3 | D-serine + H2O + O2 | - |
Homo sapiens | 2-oxo-3-hydroxypropionic acid + NH3 + H2O2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.4.3.3 | D-amino acid oxidase | - |
Homo sapiens |
1.4.3.3 | DAAO | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.4.3.3 | FAD | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.4.3.3 | 0.0000014 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4H-furo[3,2-b]pyrrole-5-carboxylic acid | |
1.4.3.3 | 0.0000014 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[2-(3-fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.0000015 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[2-(3,5-difluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.000002 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[2-(2-fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.0000021 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-[2-(3-methoxyphenyl)ethyl]pyridazin-3(2H)-one | |
1.4.3.3 | 0.0000022 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-(phenoxymethyl)pyridazin-3(2H)-one | |
1.4.3.3 | 0.0000024 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-[2-[3-(trifluoromethyl)phenyl]ethyl]pyridazin-3(2H)-one | |
1.4.3.3 | 0.0000027 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[2-(4-chlorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.0000029 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-[2-(4-methoxyphenyl)ethyl]pyridazin-3(2H)-one | |
1.4.3.3 | 0.0000031 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[2-(4-fluorophenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.0000038 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-(2-phenylethyl)pyridazin-3(2H)-one | |
1.4.3.3 | 0.0000039 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 3-hydroxy-5-(2-phenylethyl)pyridin-2(1H)-one | |
1.4.3.3 | 0.0000047 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-(2-cyclohexylethyl)-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.0000049 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-(1-phenylethyl)pyridazin-3(2H)-one | |
1.4.3.3 | 0.0000069 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 3-hydroxyquinolin-2(1H)-one | |
1.4.3.3 | 0.0000084 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-[2-[2-(trifluoromethyl)phenyl]ethyl]pyridazin-3(2H)-one | |
1.4.3.3 | 0.000012 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-[2-[4-(trifluoromethyl)phenyl]ethyl]pyridazin-3(2H)-one | |
1.4.3.3 | 0.000013 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 4-hydroxy-6-(3-phenylpropyl)pyridazin-3(2H)-one | |
1.4.3.3 | 0.000013 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[2-(3,5-dimethoxyphenyl)ethyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.000047 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 5-chloro-3-hydroxypyridin-2(1H)-one | |
1.4.3.3 | 0.000063 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.00012 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-[(E)-2-(4-chlorophenyl)vinyl]-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.00014 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 3-hydroxy-5-methylpyridin-2(1H)-one | |
1.4.3.3 | 0.0003 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-cyclohexyl-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.00067 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 6-(3,3-dimethylbutyl)-4-hydroxypyridazin-3(2H)-one | |
1.4.3.3 | 0.0015 | - |
in 50 mM potassium phosphate buffer (pH 7.5), at 22°C | Homo sapiens | 3-hydroxypyridin-2(1H)-one |